Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03624244 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Grade Endometrial Stromal Sarcoma (LGESS)

Study acronym: BFR-ESS
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Site contacts updated at 2 of 22 sitesv8
  2. Primary completion date: Jan 2025 to Jan 2028
    • Study completion date: Jan 2028 to Jan 2031
    v7
  3. Primary completion date: Oct 2023 to Jan 2025
    • Study sites: 20 to 22
    • Study completion date: Oct 2023 to Jan 2028
    v6
  4. Site details revised at 1 of 20 sitesv5
  5. Trial status: Suspended to Recruiting
    • Study sites: 13 to 20
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Recruiting to Suspended Sponsor's reason: Decision to suspend all inclusions in non-vital study during Covid-19 epidemic
    • Site details revised at 13 of 13 sites
    v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Oct 2018 to Jan 23, 2019
    • Site details revised at 13 of 13 sites
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Centre Leon Berard
70 trials monitored
See 2 trials at risk
Sarcoma
1,026 trials monitored
See 67 trials at risk
Endometrial Cancer
694 trials monitored
See 51 trials at risk
The primary objective is to compare the progression-free survival (PFS) between aromatase inhibitors interruption and aromatase inhibitors maintenance strategies in patients with a locally advanced or metastatic Low Grade Endometrial Stromal Sarcoma (LGESS).
Trial Details
NCT Number NCT03624244
Lead Sponsor Centre Leon Berard
Conditions
(from sponsor)		 Low Grade Endometrial Stromal Sarcoma
Related terms Endometrial Stromal Tumors
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov